Скажи НЕТ диабету. Готовый план действий. Патрик Холфорд
Чтение книги онлайн.

Читать онлайн книгу Скажи НЕТ диабету. Готовый план действий - Патрик Холфорд страница 31

СКАЧАТЬ style="font-size:15px;">      1

      http://www.diabetes.org.uk/about_us/News_Landing_Page/one-million-people-in-Uk-unaware-they-have-type-2-diabetes/

      2

      Diabetes Prevalence by age Group, http://www.data360.org/dsg.aspx? Data_Set_Group_id=233

      3

      International Diabetes Federation, «Global Burden: Projections 2010 and 2030», www.diabetesatlas.org

      4

      См. http://www.diabetes.org.uk/Professionals/Publications-reports-and-resources/Reportsstatistics-and-case-studies/Reports/Diabetes-prevalence-2010/

      5

      См. http://www.diabetes.org.uk/Documents/Reports/Diabetes_in_the_Uk_2010.pdf

      6

      F. B. Hu et al., «Diet, lifestyle, and the risk of type-2 diabetes mellitus in women», New England Journal of Medicine, 2001 Sep; 345: 790–7

      7

      S. E. Nissen and К. Wolski, «Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes», New England Journal of Medicine, 2007 Jun; 356 (24): 2457–71

      8

      European Medicines agency, «European Medicines agency recommends suspension of avandia, avandamet and avaglim», press release, 23 Sep 2010

      9

      Medical News Today, «Part of ACCORD study halted due to safety concerns, Canada», press release, 11 Feb 2008

      10

      DiabetesinControl.com, «Insulin users have 50 % higher cancer risk: Causes unclear», press release, 2 Sep 2010

      11

      S. L. Bowker, et al., «Increased Cancer-related mortality for patients with type-2 diabetes who use sulfonylureas or insulin», Diabetes Care, 2006 Feb; 29 (2); 254–8

      12

      G. Reaven, «Role of insulin resistance in human disease», Diabetes, 1988;37:1595–1607

      13

      E. Bonora, et al., «Prevalence of insulin resistance in metabolic disorders: the Bruneck Study», Diabetes, 1998 oct; 47 (10): 1643–9

      14

      T. M. Wallace, et al., «Use and abuse of HOMA modeling», Diabetes Care, 2004;27 (6): 1487–95

      15

      A. Esteghamati, et al., «Optimal threshold of homeostasis model assessment for insulin resistance in an iranian population: the implication of metabolic syndrome to detect insulin resistance», Diabetes Research and Clinical Practice, 2009 Jun; 84 (3): 279–87; также см. A. Esteghamati, et al., «Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SURFNCD-2007)», Nutrition and Metabolism, 2010 apr 7; 7: 26; see also I. Madeira, et al., «Cut-off point for Homeostatic Model assessment for insulin Resistance (HOMA-IR) index established from Receiver operating Characteristic (ROC) curve in the detection of metabolic syndrome in overweight pre-pubertal children», Arq Bras Endocrinol Metabol, 2008 Dec; 52 (9): 1466–73; также см. Z. Radikova, et al., «Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects», Experimental and Clinical Endocrinology & Diabetes, 2006 May; 114 (5): 249–56; также см. B. Kuwana, et al., «Reference value and cut-off value for diagnosis of insulin resistance in type-2 diabetes mellitus», Rinsho Byori, 2002 apr; 50 (4): 398–403; также см. J. Ascaso, et al., «Insulin resistance quantification by fasting insulin plasma values and HOMA index in a nondiabetic population». Medicina Clinica (Barc), 2001 Nov 3; 117 (14): 530–3

      16

      E. Selvin, et al., «Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults», New England Journal of Medicine, 2010 Mar 4; 362 (9): 800–11

      17

      D. Edelman, et al., «Utility of hemoglobin a1c in predicting diabetes risk», Journal of General Internal Medicine, 2004; 19: 1175–80

      18

      C. L. Rohlfing, et al., «Use of GHb (HbA1c) in Screening for Undiagnosed Diabetes in the U.S. Population», Diabetes Care, 2000; 23: 187–191

      19

      N. Sarwar, et al., «Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review» Public Library of Science Med, 2010 May 25; 7 (5): e1000278

      20

      R. M. Krauss, «Carbohydrates raise LDL: atherogenic lipoprotein phenotype and dietgene interactions», Journal of Nutrition, 2001 Feb; 131 (2): 340S-3S

      21

      E. S. Ford, et al., «Hypertriglyceridemia and its pharmacologic treatment among US Adults», Archives of Internal Medicine, 2009; 169 (6): 572–8

      22

      E. J. Parks, et al., «Dietary sugars stimulate fatty acid synthesis in adults», Journal of Nutrition, 2008 Jun; 138 (6): 1039–46

      23

      Dr. W.C. Willett, Symposium on Cancer Prevention, annual meeting of the American association for the advancement of Science, March 2008

      24

      J. Ahn, et al., «Adiposity, adult weight change, and postmenopausal breast cancer risk», Archives of Internal Medicine, 2007 oct; 167 (19): 2091–102

      25

      M. J. Gunter, et al., «Insulin, insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women», Journal of the National Cancer Institute, 2009 Jan; 101 (1): 48–60

      26

      M. Pollak, et al., «Insulin analogues and cancer risk: Cause for concern or cause celebre?», International Journal of Clinical Practice, 2010; 64: 628–36

СКАЧАТЬ